-
1
-
-
84984868774
-
-
Regionalt cancercentrum Stockholm/Gotland og Syd
-
Nationell rapport för Testikkelcancerregistret. Seminom och Non-seminom 2012: Regionalt cancercentrum Stockholm/Gotland og Syd 2013.
-
(2013)
Seminom och Non-seminom 2012
-
-
-
2
-
-
34247374725
-
Controversies in the management of clinical stage I testis cancer
-
de Wit R, Fizazi K. Controversies in the management of clinical stage I testis cancer. J Clin Oncol 2006; 24: 5482-5492.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5482-5492
-
-
de Wit, R.1
Fizazi, K.2
-
3
-
-
0038222521
-
Surveillance in stage I testicular cancer
-
discussion 83-75
-
Daugaard G, Petersen PM, Rorth M. Surveillance in stage I testicular cancer. APMIS 2003; 111: 76-83; discussion 83-75.
-
(2003)
APMIS
, vol.111
, pp. 76-83
-
-
Daugaard, G.1
Petersen, P.M.2
Rorth, M.3
-
4
-
-
77950592867
-
Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy
-
Kollmannsberger C, Moore C, Chi KN et al. Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy. Ann Oncol 2010; 21: 1296-1301.
-
(2010)
Ann Oncol
, vol.21
, pp. 1296-1301
-
-
Kollmannsberger, C.1
Moore, C.2
Chi, K.N.3
-
5
-
-
79952280455
-
Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's Experience
-
Sturgeon JF, Moore MJ, Kakiashvili DM et al. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's Experience. Eur Urol 2011; 59: 556-562.
-
(2011)
Eur Urol
, vol.59
, pp. 556-562
-
-
Sturgeon, J.F.1
Moore, M.J.2
Kakiashvili, D.M.3
-
6
-
-
0029866244
-
Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report
-
Cullen MH, Stenning SP, Parkinson MC et al. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol 1996; 14: 1106-1113.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1106-1113
-
-
Cullen, M.H.1
Stenning, S.P.2
Parkinson, M.C.3
-
7
-
-
65549112965
-
Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program
-
Tandstad T, Dahl O, Cohn-Cedermark G et al. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program. J Clin Oncol 2009; 27: 2122-2128.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2122-2128
-
-
Tandstad, T.1
Dahl, O.2
Cohn-Cedermark, G.3
-
8
-
-
84866775094
-
Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours
-
Cullen M. Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours. Ann Oncol 2012; 23(Suppl 10): x342-x348.
-
(2012)
Ann Oncol
, vol.23
, pp. x342-x348
-
-
Cullen, M.1
-
9
-
-
0344604538
-
Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors
-
Bohlen D, Borner M, Sonntag RW et al. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol 1999; 161: 1148-1152.
-
(1999)
J Urol
, vol.161
, pp. 1148-1152
-
-
Bohlen, D.1
Borner, M.2
Sonntag, R.W.3
-
10
-
-
46449084133
-
Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group
-
Albers P, Siener R, Krege S et al. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol 2008; 26: 2966-2972.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2966-2972
-
-
Albers, P.1
Siener, R.2
Krege, S.3
-
11
-
-
65549088972
-
Vox populi: using community-based studies to determine best management of early-stage nonseminoma
-
Nichols CR, Kollmannsberger C. Vox populi: using community-based studies to determine best management of early-stage nonseminoma. J Clin Oncol 2009; 27: 2114-2116.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2114-2116
-
-
Nichols, C.R.1
Kollmannsberger, C.2
-
12
-
-
84875591927
-
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
-
Beyer J, Albers P, Altena R et al. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 2013; 24: 878-888.
-
(2013)
Ann Oncol
, vol.24
, pp. 878-888
-
-
Beyer, J.1
Albers, P.2
Altena, R.3
-
13
-
-
79959546636
-
EAU guidelines on testicular cancer: 2011 update
-
Albers P, Albrecht W, Algaba F et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011; 60: 304-319.
-
(2011)
Eur Urol
, vol.60
, pp. 304-319
-
-
Albers, P.1
Albrecht, W.2
Algaba, F.3
-
14
-
-
77951177381
-
Canadian consensus guidelines for the management of testicular germ cell cancer
-
Wood L, Kollmannsberger C, Jewett M et al. Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J 2010; 4: e19-e38.
-
(2010)
Can Urol Assoc J
, vol.4
, pp. e19-e38
-
-
Wood, L.1
Kollmannsberger, C.2
Jewett, M.3
-
15
-
-
77956104590
-
Long-term follow-up after riskadapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study
-
Tandstad T, Cohn-Cedermark G, Dahl O et al. Long-term follow-up after riskadapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. Ann Oncol 2010; 21: 1858-1863.
-
(2010)
Ann Oncol
, vol.21
, pp. 1858-1863
-
-
Tandstad, T.1
Cohn-Cedermark, G.2
Dahl, O.3
-
16
-
-
79956308293
-
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group
-
Olofsson SE, Tandstad T, Jerkeman M et al. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group. J Clin Oncol 2011; 29: 2032-2039.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2032-2039
-
-
Olofsson, S.E.1
Tandstad, T.2
Jerkeman, M.3
-
17
-
-
0031037241
-
International Germ Cell Cancer Collaborative Group
-
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15: 594-603.
-
(1997)
J Clin Oncol
, vol.15
, pp. 594-603
-
-
-
18
-
-
36749062011
-
Long-term follow-up results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis
-
Westermann DH, Schefer H, Thalmann GN et al. Long-term follow-up results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. J Urol 2008; 179: 163-166.
-
(2008)
J Urol
, vol.179
, pp. 163-166
-
-
Westermann, D.H.1
Schefer, H.2
Thalmann, G.N.3
-
19
-
-
33745075685
-
Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy
-
Gilbert DC, Norman AR, Nicholl J et al. Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy. BJU Int 2006; 98: 67-69.
-
(2006)
BJU Int
, vol.98
, pp. 67-69
-
-
Gilbert, D.C.1
Norman, A.R.2
Nicholl, J.3
-
20
-
-
84869231872
-
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
-
Haugnes HS, Bosl GJ, Boer H et al. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol 2012; 30: 3752-3763.
-
(2012)
J Clin Oncol
, vol.30
, pp. 3752-3763
-
-
Haugnes, H.S.1
Bosl, G.J.2
Boer, H.3
-
21
-
-
77952881067
-
Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy
-
Brydoy M, Fossa SD, Klepp O et al. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur Urol 2010; 58: 134-140.
-
(2010)
Eur Urol
, vol.58
, pp. 134-140
-
-
Brydoy, M.1
Fossa, S.D.2
Klepp, O.3
-
22
-
-
65549149701
-
Long-term cognitive function among testicular cancer survivors treated with chemotherapy
-
Skoogh J, Steineck G, Stierner U et al. Long-term cognitive function among testicular cancer survivors treated with chemotherapy. J Clin Oncol 2008; 26 (suppl); abstr 5035.
-
(2008)
J Clin Oncol
, vol.26
-
-
Skoogh, J.1
Steineck, G.2
Stierner, U.3
-
23
-
-
70449358522
-
Sperm DNA integrity in cancer patients: the effect of disease and treatment
-
Stahl O, Eberhard J, Cavallin-Stahl E et al. Sperm DNA integrity in cancer patients: the effect of disease and treatment. Int J Androl 2009; 32: 695-703.
-
(2009)
Int J Androl
, vol.32
, pp. 695-703
-
-
Stahl, O.1
Eberhard, J.2
Cavallin-Stahl, E.3
-
24
-
-
27944437869
-
Paternity following treatment for testicular cancer
-
Brydoy M, Fossa SD, Klepp O et al. Paternity following treatment for testicular cancer. J Natl Cancer Inst 2005; 97: 1580-1588.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1580-1588
-
-
Brydoy, M.1
Fossa, S.D.2
Klepp, O.3
-
25
-
-
67649965345
-
Pulmonary function in long-term survivors of testicular cancer
-
Haugnes HS, Aass N, Fossa SD et al. Pulmonary function in long-term survivors of testicular cancer. J Clin Oncol 2009; 27: 2779-2786.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2779-2786
-
-
Haugnes, H.S.1
Aass, N.2
Fossa, S.D.3
-
26
-
-
33847330070
-
Components of the metabolic syndrome in long-term survivors of testicular cancer
-
Haugnes HS, Aass N, Fossa SD et al. Components of the metabolic syndrome in long-term survivors of testicular cancer. Ann Oncol 2007; 18: 241-248.
-
(2007)
Ann Oncol
, vol.18
, pp. 241-248
-
-
Haugnes, H.S.1
Aass, N.2
Fossa, S.D.3
-
27
-
-
84891506358
-
Active surveillance is the preferred approach to clinical stage I testicular cancer
-
Nichols CR, Roth B, Albers P et al. Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol 2013; 31: 3490-3493.
-
(2013)
J Clin Oncol
, vol.31
, pp. 3490-3493
-
-
Nichols, C.R.1
Roth, B.2
Albers, P.3
|